D'AURIA, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 436
EU - Europa 185
AS - Asia 70
AF - Africa 3
SA - Sud America 1
Totale 695
Nazione #
US - Stati Uniti d'America 436
IT - Italia 51
UA - Ucraina 39
SE - Svezia 37
SG - Singapore 34
FI - Finlandia 18
DE - Germania 17
IN - India 16
CN - Cina 14
IE - Irlanda 8
ID - Indonesia 5
RU - Federazione Russa 5
FR - Francia 2
GB - Regno Unito 2
RO - Romania 2
TG - Togo 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
EE - Estonia 1
HK - Hong Kong 1
MK - Macedonia 1
SC - Seychelles 1
Totale 695
Città #
Fairfield 71
Woodbridge 61
Houston 46
Ashburn 29
Singapore 26
Chandler 24
Cambridge 22
Seattle 18
Jacksonville 16
Ann Arbor 15
Wilmington 14
San Paolo di Civitate 12
Santa Clara 12
Helsinki 11
Milan 9
Princeton 9
Boston 8
Dublin 8
Lawrence 8
Beijing 7
Plano 7
Rome 7
Andover 5
Fremont 5
Jakarta 5
Falkenstein 4
Moscow 4
Norwalk 4
Naples 3
San Diego 3
Dearborn 2
Lomé 2
Millbury 2
Munich 2
New York 2
Pescara 2
Sacramento 2
Varedo 2
Boardman 1
Bremen 1
Dallas 1
Düsseldorf 1
Edinburgh 1
Federal 1
Guidonia 1
Hangzhou 1
Hefei 1
Hong Kong 1
Indore 1
Kochi 1
Lamporecchio 1
Laurel 1
Levallois-perret 1
Mahé 1
Mannheim 1
Nanjing 1
Newark 1
Saint Paul 1
Shantou 1
Sofia 1
Tallinn 1
Torino 1
Turin 1
Vigonza 1
Totale 515
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 100
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: Predictive value of early specific toxicities 95
Neo-adjuvant and adjuvant chemotherapy in bladder cancer. 90
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. 88
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy 86
Adjuvant chemotherapy in esophageal cancer 55
Induction therapy before surgery for non-small cell lung cancer 43
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 43
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 38
Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study 38
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study 20
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study 14
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 13
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study 7
Totale 730
Categoria #
all - tutte 2.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 20 16 24 14 18 9 4
2020/202168 15 8 2 10 1 10 0 5 1 10 4 2
2021/202291 0 3 9 4 16 2 0 6 8 9 13 21
2022/2023114 20 35 9 4 12 10 4 5 10 0 4 1
2023/202452 1 7 0 4 5 4 0 1 4 9 11 6
2024/2025116 3 10 13 36 27 27 0 0 0 0 0 0
Totale 730